OncoVantaHealthPrecision Oncology
Therapy Matrix
Hernexeos (zongertinib)Rx Only

Form

film-coated tablets

Strength

60 mg

Pack

60 tablets

Lung Cancer

Hernexeos

zongertinib · 60 mg

Efficacy Gauge · Clinical Signal

Target Engagement92%
Progression-Free Survival78%
Tolerability Profile84%

Mechanism of Action

Zongertinib is an oral HER2 tyrosine-kinase inhibitor that selectively blocks aberrant HER2 signaling in tumors bearing activating HER2 mutations, suppressing downstream proliferation pathways while sparing wild-type EGFR signaling.

Manufacturer

Boehringer Ingelheim

Target Protein

HER2

Delivery

Tablets

Quantity

60 tablets

Critical Safety Information

Hernexeos is a prescription therapy. It may interact with CYP3A4 inhibitors and hormonal treatments. Do not co-administer with grapefruit. Report pregnancy or nursing status immediately. Requires ongoing hepatic monitoring.

Pricing Tier · Select Quantity

Total

$2,450

All orders require a valid prescription and clinical review before fulfillment. Final pricing confirmed after verification.

OncoVantaHealth

A clinical-grade command center for life-extending oncology therapies. Precision access, transparent pricing, and scientifically vetted care.

Rx Only · Prescription Therapies

Affiliated with Princess Margaret Cancer Centre · UHN

Support

This storefront provides access to prescription oncology therapies. All orders require a valid prescription and clinical review. Not a substitute for medical advice.